Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Labcorp
LH
Market cap
$22B
Overview
Fund Trends
Analyst Outlook
Journalist POV
266.73
USD
-2.14
0.8%
At close
Updated
Apr 15, 4:00 PM EDT
Pre-market
After hours
266.73
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-0.8%
5 days
-2.08%
1 month
-0.04%
3 months
-0.8%
6 months
-5.67%
Year to date
5.99%
1 year
18.01%
5 years
19.69%
10 years
159.69%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
44.4%
Negative
Positive
Neutral
Negative
Neutral
PRNewsWire
19 hours ago
Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes
First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams act quickly when every second counts Fentanyl Urine Visual Test is available through Labcorp Point of Care, previously known as MEDTOX Diagnostics BURLINGTON, N.C., April 15, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Labcorp Fentanyl Urine Visual Test, the first U.S. Food and Drug Administration (FDA)-cleared rapid fentanyl test of its kind manufactured in the United States.
Positive
Zacks Investment Research
yesterday
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Neutral
PRNewsWire
yesterday
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
Platform leverages agentic AI and diverse healthcare datasets to transform and speed drug development BURLINGTON, N.C., April 14, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a new AI-powered real-world data platform, designed to help researchers and biopharmaceutical companies analyze Alzheimer's disease-related data faster.
Neutral
PRNewsWire
2 days ago
Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide
Collaboration aims to speed the discovery, development and national availability of specialized pediatric diagnostics BURLINGTON, N.C. and PHILADELPHIA, April 13, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Children's Hospital of Philadelphia (CHOP), the nation's first pediatric hospital, announced today a strategic collaboration to accelerate the discovery, development and nationwide availability of specialized pediatric diagnostics.
Neutral
PRNewsWire
6 days ago
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., April 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock.
Positive
Zacks Investment Research
8 days ago
Should You Continue to Hold LH Stock in Your Portfolio?
Labcorp's expansion in specialty testing and efficiency gains support growth, but macroeconomic and competitive pressures could weigh on its outlook.
Positive
Zacks Investment Research
9 days ago
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Neutral
PRNewsWire
15 days ago
Labcorp to Announce First Quarter Financial Results on April 30, 2026
BURLINGTON, N.C., March 31, 2026 /PRNewswire/ -- Labcorp Holdings Inc.
Positive
Zacks Investment Research
20 days ago
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Negative
Zacks Investment Research
27 days ago
Why Is Labcorp (LH) Down 4.6% Since Last Earnings Report?
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close